Indicators

Latest News about GSK plc

Recent news which mentions GSK plc

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

April 01, 2025

Cramer's Lightning Round: 'You've got a winner in Cheesecake Factory'

March 04, 2025

Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary

February 04, 2025

Pharma is hopeful about Trump's second term — here's what to expect for drugmakers

January 26, 2025

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

January 17, 2025

Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

January 14, 2025

Vaccine maker stocks fall on reports Trump plans to tap RFK Jr. to lead HHS

November 14, 2024

Wednesday's big stock stories: What’s likely to move the market in the next trading session

October 29, 2024

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval

October 17, 2024

Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next

September 24, 2024

Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future

September 12, 2024

Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market

August 01, 2024

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline

June 28, 2024

FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections

June 17, 2024

FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach

June 07, 2024

Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits

June 03, 2024

FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product

May 31, 2024

Moderna says FDA delayed RSV vaccine approval to end of May

May 10, 2024

FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic

April 30, 2024

Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

April 09, 2024

Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients

March 26, 2024

Pfizer RSV vaccine maintains protection in older adults over two seasons in trial

February 29, 2024

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

February 27, 2024

Cramer's Lightning Round: 'Hold off' on Kroger

February 05, 2024

GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost

January 31, 2024

5 things to know before the stock market opens Monday

January 29, 2024

Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

January 14, 2024

RSV vaccine from GSK shows potential to protect adults 50 to 59

October 25, 2023

Moderna combination Covid, flu vaccine moves to final stage trial after positive data

October 04, 2023

Covid, RSV and flu vaccines are now available — here's how to decide whether to get them together

September 15, 2023

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.